BC Platforms signs Strategic Collaboration Agreement with AWS to accelerate healthcare and life sciences innovation
BC Platforms signs a Strategic Collaboration Agreement with AWS to scale secure, AI-powered research environments.
BC Platforms signs a Strategic Collaboration Agreement with AWS to scale secure, AI-powered research environments.
There is no excerpt because this is a protected post.
A closer look at how RWD, analytics, and AI are reshaping standard of care insights and evidence generation across the drug lifecycle.
BC Platforms earns the SEF.Growth High‑Potential label for secure, scalable innovation in health data.
NVIDIA accelerated computing now available in BC Mosaic TRE, delivering up to 80x faster analytics across multi-modal health data.
BC Mosaic, our trusted research environment, now on AWS Marketplace for secure, AI-powered federated data analysis.
Zurich – 5th, February 2026 BC Platforms, a global leader in healthcare data, technology, and analytics today announced a strategic partnership with OmicsBank, a healthcare AI-ready data infrastructure company specializing in enabling access to large-scale, research-ready longitudinal and multi-modal real-world clinical and multi-omics datasets from emerging markets. The partnership expands BC Platforms’ global data partner
We partner with GeneVault to expand access to RWD from underrepresented populations across Asia, the Middle East, Africa, and Latin America.
BC Platforms in the press: Signify Research reviews BC Catalyst, our AI-powered platform for life sciences and precision medicine.
For press and media inquiries, contact our communications team at media@bcplatforms.com.
For partnerships, business opportunities, and all other inquiries, please fill out this form